p300 expression is induced by oxygen deficiency and protects neuron cells from damage

Brain Research

Volumn 1254, Issue , 2009, Pages 1-9

  Tan, Xiao Ling ^a   Zhai, Yu ^a   Gao, Wen Xiang ^a   Fan, You Ming ^a   Liu, Fu Yu ^a   Huang, Qing Yuan ^a   Gao, Yu Qi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hippocampus; Hypoxia oxygen deficiency; Nerve growth factor; p300; PC12 cell; shRNA

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, RAT; MESSENGER RNA; TUBULIN;

ANIMAL; ANOXIA; ARTICLE; BRAIN; CELL HYPOXIA; CELL STRAIN; GENETIC TRANSFECTION; GENETICS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WISTAR RAT;

ANIMALS; ANOXIA; BRAIN; CELL HYPOXIA; E1A-ASSOCIATED P300 PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; PC12 CELLS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUBULIN; UP-REGULATION;

EID: 58549109689     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.11.092     Document Type: Article

References (31)

1. Arany Z., Huang L.E., Eckner R., Bhattacharya S., Jiang C., Goldberg M.A., Bunn H.F., and Livingston D.M. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 12969-12973
2. Blagosklonny M.V., An W.G., Romanova L.Y., Trepel J., Fojo T., and Neckers L. p53 inhibits hypoxia-inducible factor-stimulated transcription. J. Biol. Chem. 273 (1998) 11995-11998
3. Blobel G.A. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95 (2000) 745-755
4. Conrad P.W., Conforti L., Kobayashi S., Beitner-Johnson D., Rust R.T., Yuan Y., Kim H.W., Kim R.H., Seta K., and Millhorn D.E. The molecular basis of O2-sensing and hypoxia tolerance in pheochromocytoma cells. Comp. Biochem. Physiol., B Biochem. Mol. Biol. 128 (2001) 187-204
5. Culmsee C., Siewe J., Junker V., Retiounskaia M., Schwarz S., Camandola S., El-Metainy S., Behnke H., Mattson M.P., and Krieglstein J. Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J. Neurosci. 23 (2003) 8586-8595
6. Eckner R., Ewen M.E., Newsome D., Gerdes M., DeCaprio J.A., Lawrence J.B., and Livingston D.M. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8 (1994) 869-884
7. Ferrante R.J., Kubilus J.K., Lee J., Ryu H., Beesen A., Zucker B., Smith K., Kowall N.W., Ratan R.R., Luthi-Carter R., and Hersch S.M. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 23 (2003) 9418-9427
8. Gardian G., Browne S.E., Choi D.K., Klivenyi P., Gregorio J., Kubilus J.K., Ryu H., Langley B., Ratan R.R., Ferrante R.J., and Beal M.F. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J. Biol. Chem. 280 (2005) 556-563
9. Goodman R.H., and Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14 (2000) 1553-1577
10. Hockly E., Richon V.M., Woodman B., Smith D.L., Zhou X., Rosa E., Sathasivam K., Ghazi-Noori S., Mahal A., Lowden P.A., Steffan J.S., Marsh J.L., Thompson L.M., Lewis C.M., Marks P.A., and Bates G.P. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2041-2046
11. Hockly E., Woodman B., Mahal A., Lewis C.M., and Bates G. Standardization and statistical approaches to therapeutic trials in the R6/2 mouse. Brain Res. Bull. 61 (2003) 469-479
12. Kalkhoven E. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68 (2004) 1145-1155
13. Li Y., Yuan Z., Liu B., Sailhamer E.A., Shults C., Velmahos G.C., Demoya M., and Alam H.B. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition. J. Trauma 64 (2008) 863-870 discussion 870-871
14. Maggirwar S.B., Ramirez S., Tong N., Gelbard H.A., and Dewhurst S. Functional interplay between nuclear factor-kappaB and c-Jun integrated by coactivator p300 determines the survival of nerve growth factor-dependent PC12 cells. J. Neurochem. 74 (2000) 527-539
15. Misiti S., Schomburg L., Yen P.M., and Chin W.W. Expression and hormonal regulation of coactivator and corepressor genes. Endocrinology 139 (1998) 2493-2500
16. Nair A.M., Michael B., Datta A., Fernandez S., and Lairmore M.D. Calcium-dependent enhancement of transcription of p300 by human T-lymphotropic type 1 p12I. Virology 353 (2006) 247-257
17. Ogawa H., Nishi M., and Kawata M. Localization of nuclear coactivators p300 and steroid receptor coactivator 1 in the rat hippocampus. Brain Res. 890 (2001) 197-202
18. Ravi R., Mookerjee B., van Hensbergen Y., Bedi G.C., Giordano A., El-Deiry W.S., Fuchs E.J., and Bedi A. p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res. 58 (1998) 4531-4536
19. Rouaux C., Jokic N., Mbebi C., Boutillier S., Loeffler J.P., and Boutillier A.L. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J. 22 (2003) 6537-6549
20. Ryou S.M., Kang K.H., Jeong M.H., Kim J.W., An J.H., Lee S.Y., Jang S., Song P.I., and Choi K.H. Functional cross-talk between p73β and NF-kB mediated by p300. Biochem. Biophys. Res. Commun. 345 (2006) 623-630
21. Schmid T., Zhou J., and Brune B. HIF-1 and p53: communication of transcription factors under hypoxia. J. Cell. Mol. Med. 8 (2004) 423-431
22. Schmid T., Zhou J., Kohl R., and Brune B. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). Biochem. J. 380 (2004) 289-295
23. Seta K., Kim H.W., Ferguson T., Kim R., Pathrose P., Yuan Y., Lu G., Spicer Z., and Millhorn D.E. Genomic and physiological analysis of oxygen sensitivity and hypoxia tolerance in PC12 cells. Ann. N.Y. Acad. Sci. 971 (2002) 379-388
24. Seta K.A., Yuan Y., Spicer Z., Lu G., Bedard J., Ferguson T.K., Pathrose P., Cole-Strauss A., Kaufhold A., and Millhorn D.E. The role of calcium in hypoxia-induced signal transduction and gene expression. Cell Calcium 36 (2004) 331-340
25. Spicer Z., and Millhorn D.E. Oxygen sensing in neuroendocrine cells and other cell types: pheochromocytoma (PC12) cells as an experimental model. Endocr. Pathol. 14 (2003) 277-291
26. Tan X.L., Huang X.Y., Gao W.X., Zai Y., Huang Q.Y., Luo Y.J., and Gao Y.Q. CoCl(2)-induced expression of p300 promotes neuronal-like PC12 cell damage. Neurosci. Lett. 441 (2008) 272-276
27. Vengellur A., Phillips J.M., Hogenesch J.B., and LaPres J.J. Gene expression profiling of hypoxia signaling in human hepatocellular carcinoma cells. Physiol. Genomics 22 (2005) 308-318
28. Vleugel M.M., Shvarts D., van der Wall E., and van Diest P.J. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer. Hum. Pathol. 37 (2006) 1085-1092
29. Vo N., and Goodman R.H. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276 (2001) 13505-13508
30. Webster G.A., and Perkins N.D. Transcriptional cross talk between NF-kappaB and p53. Mol. Cell. Biol. 19 (1999) 3485-3495
31. Youn H.D., Chatila T.A., and Liu J.O. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 19 (2000) 4323-4331